Dannex Ayrton Starwin (XGHA:DASPHARMA) Other Stockholders Equity: GHS0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:DASPHARMA Dannex Ayrton Starwin PLC XGHA:DASPHARMA
4 GF Score
Price GHS0.44
! 1 Warning Sign
View Full Analysis

What is Dannex Ayrton Starwin Other Stockholders Equity?

Dannex Ayrton Starwin XGHA:DASPHARMA 4 Other Stockholders Equity is GHS0.00 Mil as of . 20. GuruFocus rates XGHA:DASPHARMA with a GF Score™ of 4/100. The stock has 1 warning sign investors should review.

Dannex Ayrton Starwin's Other Stockholders Equity for the quarter that ended in . 20 was GHS0.00 Mil.

Dannex Ayrton Starwin Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Dannex Ayrton Starwin's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dannex Ayrton Starwin Other Stockholders Equity Chart

Dannex Ayrton Starwin Annual Data
Trend
Other Stockholders Equity

Dannex Ayrton Starwin Semi-Annual Data
Other Stockholders Equity
XGHA:DASPHARMA
4GF Score
Dannex Ayrton Starwin PLC XGHA:DASPHARMA
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dannex Ayrton Starwin Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of GHS0.00 Mil mean?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a Other Stockholders Equity of GHS0.00 Mil as of . 20. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Dannex Ayrton Starwin and its competitors.
Is Dannex Ayrton Starwin's Other Stockholders Equity too high?
Dannex Ayrton Starwin's current Other Stockholders Equity is GHS0.00 Mil. Overall, Dannex Ayrton Starwin has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Dannex Ayrton Starwin's Other Stockholders Equity compare to ?
Dannex Ayrton Starwin's Other Stockholders Equity of GHS0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Dannex Ayrton Starwin and its competitors. Dannex Ayrton Starwin's current Other Stockholders Equity is GHS0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dannex Ayrton Starwin stock overvalued right now?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a current Other Stockholders Equity of GHS0.00 Mil. The current Other Stockholders Equity is GHS0.00 Mil. Dannex Ayrton Starwin's overall GF Score™ is 4/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Dannex Ayrton Starwin (XGHA:DASPHARMA), the current Other Stockholders Equity is GHS0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dannex Ayrton Starwin Business Description

Comparable Companies
Address No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.
4GF Score

Get the complete analysis for XGHA:DASPHARMA

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.44
Price